全文获取类型
收费全文 | 27268篇 |
免费 | 2065篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 186篇 |
儿科学 | 856篇 |
妇产科学 | 615篇 |
基础医学 | 4095篇 |
口腔科学 | 445篇 |
临床医学 | 3156篇 |
内科学 | 5792篇 |
皮肤病学 | 545篇 |
神经病学 | 3284篇 |
特种医学 | 518篇 |
外科学 | 2561篇 |
综合类 | 189篇 |
一般理论 | 29篇 |
预防医学 | 2870篇 |
眼科学 | 303篇 |
药学 | 1877篇 |
中国医学 | 45篇 |
肿瘤学 | 2058篇 |
出版年
2023年 | 235篇 |
2022年 | 415篇 |
2021年 | 815篇 |
2020年 | 538篇 |
2019年 | 803篇 |
2018年 | 860篇 |
2017年 | 632篇 |
2016年 | 736篇 |
2015年 | 793篇 |
2014年 | 1020篇 |
2013年 | 1326篇 |
2012年 | 2143篇 |
2011年 | 2159篇 |
2010年 | 1146篇 |
2009年 | 983篇 |
2008年 | 1689篇 |
2007年 | 1756篇 |
2006年 | 1707篇 |
2005年 | 1600篇 |
2004年 | 1442篇 |
2003年 | 1298篇 |
2002年 | 1166篇 |
2001年 | 276篇 |
2000年 | 239篇 |
1999年 | 267篇 |
1998年 | 254篇 |
1997年 | 181篇 |
1996年 | 169篇 |
1995年 | 156篇 |
1994年 | 127篇 |
1993年 | 121篇 |
1992年 | 129篇 |
1991年 | 131篇 |
1990年 | 131篇 |
1989年 | 120篇 |
1988年 | 114篇 |
1987年 | 91篇 |
1986年 | 106篇 |
1985年 | 96篇 |
1984年 | 94篇 |
1983年 | 89篇 |
1982年 | 76篇 |
1981年 | 70篇 |
1980年 | 68篇 |
1979年 | 88篇 |
1978年 | 76篇 |
1977年 | 68篇 |
1976年 | 67篇 |
1974年 | 66篇 |
1972年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
Background
Flexor digitorum superficialis (FDS) arch is a site of compression in pronator syndrome yet little is known about its anatomic structure. The purpose of the study is to delineate the surgical anatomy of the FDS arch along with its relationship to the anterior interosseous nerve (AIN) takeoff.Methods
Thirty-eight cadavers were dissected using a modified Henry’s approach. The FDS arch was identified, and its distance to the antebrachial crease and medial and lateral epicondyle were measured. The FDS arch was divided in a sequential fashion until adequate decompression of the median nerve was achieved. The total length of the release was measured. The takeoff of the AIN was identified in relation to the FDS arch.Results
Two types of the FDS arch were discovered, a distinct fibrous arch and an indistinct fibrous arch with vertical fibers blending into overlying fascia. Only 42 % of specimens had a distinct FDS arch averaging 1.69 cm in length. The majority of specimens had an indistinct arch, and of those, 77 % had overlying muscle, requiring an average release of 2.6 cm. The AIN branched at or distal to the FDS arch in 74 % of specimens, and only 8 % was found to have an ulnar-sided origin off the median nerve.Conclusions
A longer surgical release is needed with indistinct FDS arches. Overlying muscle during dissection may be indicative of an indistinct arch. Dissection along the ulnar side of the median nerve can possibly decrease the chance of injury to the AIN during decompression. 相似文献996.
997.
Peter Molenaar Torsten Christ Emanuel Berk Andreas Engel Katherine T. Gillette Alejandro Galindo-Tovar Ursula Ravens Alberto J. Kaumann 《Naunyn-Schmiedeberg's archives of pharmacology》2014,387(7):629-640
The β-blockers carvedilol and metoprolol provide important therapeutic strategies for heart failure treatment. Therapy with metoprolol facilitates the control by phosphodiesterase PDE3, but not PDE4, of inotropic effects of catecholamines in human failing ventricle. However, it is not known whether carvedilol has the same effect. We investigated whether the PDE3-selective inhibitor cilostamide (0.3 μM) or PDE4-selective inhibitor rolipram (1 μM) modified the positive inotropic and lusitropic effects of catecholamines in ventricular myocardium of heart failure patients treated with carvedilol. Right ventricular trabeculae from explanted hearts of nine carvedilol-treated patients with terminal heart failure were paced to contract at 1 Hz. The effects of (-)-noradrenaline, mediated through β1-adrenoceptors (β2-adrenoceptors blocked with ICI118551), and (-)-adrenaline, mediated through β2-adrenoceptors (β1-adrenoceptors blocked with CGP20712A), were assessed in the absence and presence of the PDE inhibitors. The inotropic potency, estimated from –logEC50s, was unchanged for (-)-noradrenaline but decreased 16-fold for (-)-adrenaline in carvedilol-treated compared to non-β-blocker-treated patients, consistent with the previously reported β2-adrenoceptor-selectivity of carvedilol. Cilostamide caused 2- to 3-fold and 10- to 35-fold potentiations of the inotropic and lusitropic effects of (-)-noradrenaline and (-)-adrenaline, respectively, in trabeculae from carvedilol-treated patients. Rolipram did not affect the inotropic and lusitropic potencies of (-)-noradrenaline or (-)-adrenaline. Treatment of heart failure patients with carvedilol induces PDE3 to selectively control the positive inotropic and lusitropic effects mediated through ventricular β2-adrenoceptors compared to β1-adrenoceptors. The β2-adrenoceptor-selectivity of carvedilol may provide protection against β2-adrenoceptor-mediated ventricular overstimulation in PDE3 inhibitor-treated patients. PDE4 does not control β1- and β2-adrenoceptor-mediated inotropic and lusitropic effects in carvedilol-treated patients. 相似文献
998.
Therese Ericsson Antje Blank Cornelia von Hagens Michael Ashton Angela Äbelö 《European journal of clinical pharmacology》2014,70(12):1453-1463
Purpose
The purpose of this study were firstly to characterize the population pharmacokinetics of artesunate (ARS) and its active metabolite dihydroartemisinin (DHA) in patients with metastatic breast cancer during long-term (>3 weeks) daily oral ARS administration and secondly to study the relationship between salivary and plasma concentrations of DHA.Methods
Drug concentration-time data from 23 patients, receiving oral ARS (100, 150, or 200 mg OD), was analyzed using nonlinear mixed effects modeling. A combined drug-metabolite population pharmacokinetic model was developed to describe the plasma pharmacokinetics of ARS and DHA in plasma. Saliva drug concentrations were incorporated as being directly proportional to plasma concentrations.Results
A first-order absorption model for ARS linked to a combined two-compartment disposition model for ARS and one-compartment disposition model for DHA provided the best fit to the data. No covariates were identified that could explain between-subject variability. A time-dependent increase in apparent elimination clearance of DHA was observed. Salivary DHA concentrations were proportionally correlated with total DHA plasma concentrations, with an estimated slope factor of 0.116.Conclusions
Population pharmacokinetics of ARS and DHA in patients with breast cancer was well described by a combined drug-metabolite model without any covariates and with an increase in apparent elimination clearance of DHA over time. The estimated DHA saliva/plasma ratio was in good agreement with the reported DHA unbound fraction in human plasma. Saliva ARS concentrations correlated poorly with plasma concentrations. This suggests the use of saliva sampling for therapeutic drug monitoring of DHA. However, further studies are warranted to investigate the robustness of this approach. 相似文献999.
Angela E. McLelland Mathew T. Martin-Iverson Richard J. Beninger 《Psychopharmacology》2014,231(22):4349-4359
Rationale
Recent case reports describe recreational use of quetiapine and drug-seeking behaviour to obtain quetiapine, an atypical antipsychotic.Objective
We examined the hypothesis that quetiapine (10, 20 or 40 mg/kg) alone or co-administered with (+)-amphetamine (0.25, 0.5, 0.75 or 2.0 mg/kg) will affect reward and/or decrease anxiety in rats, as measured by conditioned place preference (CPP) and elevated plus maze (EPM) test, respectively.Results
Quetiapine (20 mg/kg) produced greater open arm time and entries in the EPM test compared to 10 and 40 mg/kg, and quetiapine (10 mg/kg) significantly increased open arm entries and time when co-administered with (+)-amphetamine (0.5 mg/kg) compared to (+)-amphetamine (0.5 mg/kg) alone, suggesting decreased anxiety. Quetiapine (10, 20 or 40 mg/kg) produced no CPP when administered alone; the lowest dose of quetiapine (10 mg/kg) reduced CPP produced by a low dose of (+)-amphetamine (0.25 mg/kg), but had no significant effect on CPP produced by a higher dose (0.5 mg/kg).Discussion
The quetiapine-induced anxiolytic effect in the EPM might explain why humans are misusing quetiapine and combining it with (+)-amphetamine. It is possible that humans experience an anxiolytic effect of the combined drugs and relatively unaltered rewarding effects of (+)-amphetamine. The results shed some light on the question of why humans are abusing and misusing quetiapine, despite its dopamine (DA) D2 receptor antagonism; it will be the task of future studies to identify the pharmacological mechanism mediating this behaviour. 相似文献1000.
The vascular endothelium is specifically sensitive to oxidative stress, and this is one of the mechanisms that causes widespread endothelial dysfunction in most cardiovascular diseases and disorders. Protection against reactive oxygen species (ROS)-mediated oxidative damage via antioxidant mechanisms is essential for tissue maintenance and shows therapeutic potential for patients suffering from cardiovascular and metabolic disorders. Salvianolic acid B (SalB), a natural bioactive component known from Traditional Chinese Medicine, has been reported to exert cellular protection in various types of cells. However, the underlying mechanisms involved are not fully understood. Here, we showed that SalB significantly promoted the migratory and tube formation abilities of human bone marrow derived-endothelial progenitor cells (BM-EPCs) in vitro, and substantially abrogated hydrogen peroxide (H2O2)-induced cell damage. SalB down-regulated Nox4 and eNOS, as well as nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase expression upon H2O2 induction that in turn prevents oxidative-induced endothelial dysfunction. Moreover, SalB suppressed the Bax/Bcl-xL ratio and caspase-3 activation after H2O2 induction. Furthermore, our results provide mechanistic evidence that activation of the mTOR/p70S6K/4EBP1 pathways is required for both SalB-mediated angiogenic and protective effects against oxidative stress-induced cell injury in BM-EPCs. Suppression of MKK3/6-p38 MAPK-ATF2 and ERK1/2 signaling pathways by SalB significantly protected BM-EPCs against cell injury caused by oxidative stress via reduction of intracellular ROS levels and apoptosis. Taken together, by providing a mechanistic insight into the modulation of redox states in BM-EPCs by SalB, we suggest that SalB has a strong potential of being a new proangiogenic and cytoprotective therapeutic agent with applications in the field of endothelial injury-mediated vascular diseases. 相似文献